[ad_1]
MORE THAN 90 PERCENT OF CASH
The American pharmaceutical company Pfizer and the Turkish scientist Prof. Dr. The possible vaccine developed by the German biotechnology company BioNTech, of which Uğur Şahin was a founding partner, was reported to be more than 90 percent effective against the virus.
It was announced that the candidate vaccine BNT162b1 has been tested in 43,538 people in 6 countries, and there have been no serious safety issues in the trials so far.
As countries around the world compete to sign contracts for millions of vaccine doses, BioNTech previously announced plans to produce 100 million more vaccines globally by the end of 2020 and about 1.3 billion more doses by the end of 2021.
Pfizer and BioNTech signed a preliminary agreement with the US, EU, UK, Canada and Japan for the supply of the vaccine.
The companies had signed a $ 1.95 billion contract to provide 100 million doses of vaccines to the United States government this year.
The EU Commission announced yesterday that the Commission will soon sign contracts with these companies to receive up to 300 million doses of vaccine.
The EU had previously signed contracts with the pharmaceutical companies Johnson and Johnson, AstraZeneca and Sanofi-GSK to purchase vaccines, and also announced that the vaccine purchase negotiations with the companies CureVac, BioNTech-Pfizer and Moderna were successful.
